Upregulation of microRNA 181c expression in gastric cancer tissues and plasma

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 5, 2013, Pages 3063-3066

  Cui, Mei Hua ^a   Hou, Xiao Lin ^a   Lei, Xiao Yan ^a   Mu, Fang Hong ^a   Yang, Gui Bin ^a   Yue, Lin ^a   Fu, Yi ^a   Yi, Guo Xing ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

181c (miR 181c); Cancer tissue; Gastric cancer; MicroRNA; Plasma

Indexed keywords

MICRORNA; MIRN181 MICRORNA, HUMAN; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BLOOD; CANCER STAGING; CASE CONTROL STUDY; CHRONIC DISEASE; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GASTRITIS; GENETICS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; STOMACH TUMOR; STOMACH ULCER; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GASTRITIS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; STOMACH ULCER; TUMOR MARKERS, BIOLOGICAL;

EID: 84880368448     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.5.3063     Document Type: Article

References (25)

1. Brase JC, Wuttig D, Kuner R, et al (2010). Serum microRNAs as non-invasive biomarker for cancer. Mol Cancer, 9, 306.
2. Cheng H, Zhang L, Cogdell DE, et al (2011). Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One, 6, e17745.
3. Criscitiello C, Sotiriou C, Ignatiadis M (2010). Circulating tumor cells and emerging blood biomarkers in breast cancer. Curr Opin Oncol, 22, 552-8.
4. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
5. Habbe N, Koorstra JB, Mendell JT, et al (2009). MicroRNA miR- 155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther, 8, 340-6.
6. Hartgrink HH, Jansen EP, van Grieken NC, et al (2009). Gastric cancer. Lancet, 374, 477-90.
7. Hashimoto Y, Akiyama Y, Otsubo T, et al (2010). Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis. Carcinogenesis, 31, 777-84.
8. Jay C, Nemunaitis J, Chen P, et al (2007). miRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol, 26, 293-300.
9. Ji X, Takahashi R, Hiura Y, et al (2009). Plasma miR208 as a biomarker of myocardial injury. Clin Chem, 55, 1944-9.
10. Li BS, Zhao YL, Guo G, et al (2012). Plasma microRNAs, miR- 223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PloS One, 7, e41629.
11. Liu H, Zhu L, Liu B, et al (2012). Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett, 316, 196-203.
12. Liu H, Zhu L, Liu B, et al (2012). Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett, 316, 196-203.
13. Liu R, Zhang C, Hu Z, et al (2011). A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cance, 47, 784-91.
14. Lowery AJ, Miller N, Devaney A, et al (2009). MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res, 11, R27.
15. Mattie MD, Benz CC, Bowers J, et al (2006). Optimized highthroughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer, 5, 24.
16. Mitchell PS, Parkin RK, Kroh EM, et al (2008). Circulating microRNAs as stable blood based markers for cancer detection. Proc Natl Acad Sci USA, 105, 10513-8.
17. Ng EK, Chong WW, Jin H, et al (2009). Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut, 58, 1375-81.
18. Osman A (2012). MicroRNAs in health and disease-basic science and clinical applications. Clin Lab, 58, 393-402.
19. Resnick KE, Alder H, Hagan JP, et al (2009). The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real time PCR platform. Gynecol Oncol, 112, 55-9.
20. Slaby O, Lakomy R, Fadrus P, et al (2010). MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients. Neoplasma, 57, 264-9.
21. Tsujiura M, Ichikawa D, Komatsu S, et al (2010). Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer, 102, 1174-9.
22. Valadi H, Ekström K, Bossios A, et al (2007). Exosomemediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol, 9, 654-9.
23. Wang F, Sun GP, Zou YF, et al (2012). MicroRNAs as promising biomarkers for gastric cancer. Cancer Biomark, 11, 259-67.
24. Wong TS, Liu XB, Wong BY, et al (2008). Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res, 14, 2588-92.
25. Yang N, Kaur S, Volinia S, et al (2008). MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res, 68, 10307-14.